[1]
R. Yavel, J. S. Overcash, J. Zhi, E. Cutler, D. Cutler, and J. Fang, “Phase I Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects with Actinic Keratosis”, J of Skin, vol. 4, no. 6, p. s119, Oct. 2020.